Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalMolecular Cancer Therapeutics
ISSN1535-7163
DOIs
Publication statusE-pub ahead of print - 2019
MoE publication typeA1 Journal article-refereed

Cite this

@article{931a61720a5f4bfb98fba0ffdd3859b5,
title = "Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers",
author = "Talwelkar, {Sarang S.} and Nagaraj, {Ashwini S.} and Devlin, {Jennifer R.} and Annabrita Hemmes and Swapnil Potdar and Kiss, {Elina A.} and Pipsa Saharinen and Salmenkivi, {Kaisa Maria} and M{\"a}yr{\"a}np{\"a}{\"a}, {Mikko I.} and Krister Wennerberg and Emmy Verschuren",
year = "2019",
doi = "10.1158/1535-7163.MCT-18-0573",
language = "English",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research",

}

TY - JOUR

T1 - Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers

AU - Talwelkar, Sarang S.

AU - Nagaraj, Ashwini S.

AU - Devlin, Jennifer R.

AU - Hemmes, Annabrita

AU - Potdar, Swapnil

AU - Kiss, Elina A.

AU - Saharinen, Pipsa

AU - Salmenkivi, Kaisa Maria

AU - Mäyränpää, Mikko I.

AU - Wennerberg, Krister

AU - Verschuren, Emmy

PY - 2019

Y1 - 2019

U2 - 10.1158/1535-7163.MCT-18-0573

DO - 10.1158/1535-7163.MCT-18-0573

M3 - Article

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

ER -